Peptide-matrix-mediated gene transfer of an oxygen-insensitive hypoxia-inducible factor-1alpha variant for local induction of angiogenesis. - Wikidata - wikimedia - TriplyDB

Peptide-matrix-mediated gene transfer of an oxygen-insensitive hypoxia-inducible factor-1alpha variant for local induction of angiogenesis.

Peptide-matrix-mediated gene transfer of an oxygen-insensitive hypoxia-inducible factor-1alpha variant for local induction of angiogenesis.

http://www.wikidata.org/entity/Q34479397

about

Hypoxia-based strategies for angiogenic induction: the dawn of a new era for ischemia therapy and tissue regeneration Cell-controlled and spatially arrayed gene delivery from fibrin hydrogels Influence of thrombin concentration on the mechanical and morphological properties of cell-seeded fibrin hydrogels Hypoxic signaling during tissue repair and regenerative medicine Growth factors, matrices, and forces combine and control stem cells New Bioengineering Breakthroughs and Enabling Tools in Regenerative Medicine VEGF gene expression in adult human thymus fat: a correlative study with hypoxic induced factor and cyclooxygenase-2 Nanoscale strategies: treatment for peripheral vascular disease and critical limb ischemia.Two and three-dimensional gene transfer from enzymatically degradable hydrogel scaffolds Incorporation of active DNA/cationic polymer polyplexes into hydrogel scaffolds.Surface immobilization of plasmid DNA with a cell-responsive tether for substrate-mediated gene delivery Hyaluronic acid and fibrin hydrogels with concentrated DNA/PEI polyplexes for local gene delivery.Bioreducible polycations in nucleic acid delivery: past, present, and future trends.BMP2 sensitizes glioblastoma stem-like cells to Temozolomide by affecting HIF-1α stability and MGMT expression.Polyplex gene delivery modulated by redox potential gradients.Tissue engineering of replacement skin: the crossroads of biomaterials, wound healing, embryonic development, stem cells and regeneration Gene therapy and wound healing Multifunctional cell-instructive materials for tissue regeneration.Gene therapy progress and prospects: therapeutic angiogenesis for ischemic cardiovascular disease.Matrices and scaffolds for DNA delivery in tissue engineering Hypoxia-Inducible Factor (HIF)-1 regulatory pathway and its potential for therapeutic intervention in malignancy and ischemia DNA delivery from matrix metalloproteinase degradable poly(ethylene glycol) hydrogels to mouse cloned mesenchymal stem cells.Matrix-based gene delivery for tissue repair Micro/nanostructured polymeric systems for biomedical and pharmaceutical applications.Age-dependent impairment of HIF-1alpha expression in diabetic mice: Correction with electroporation-facilitated gene therapy increases wound healing, angiogenesis, and circulating angiogenic cells.Fibrin hydrogels for non-viral vector delivery in vitro Biomolecule delivery to engineer the cellular microenvironment for regenerative medicine.Prolyl hydroxylase and hypoxia inducible factor: potential targets for cancer therapy.Hypoxia inducible factor-1: its potential role in cerebral ischemia.Overcoming hypoxia to improve tissue-engineering approaches to regenerative medicine.Cell penetration: scope and limitations by the application of cell-penetrating peptides.Lentivirus delivery by adsorption to tissue engineering scaffolds.Biochemical and Biophysical Cues in Matrix Design for Chronic and Diabetic Wound Treatment.T17b murine embryonal endothelial progenitor cells can be induced towards both proliferation and differentiation in a fibrin matrix.Deletion of the oxygen-dependent degradation domain results in impaired transcriptional activity of hypoxia-inducible factors.Utilizing cell-matrix interactions to modulate gene transfer to stem cells inside hyaluronic acid hydrogels.Design and characterization of microporous hyaluronic acid hydrogels for in vitro gene transfer to mMSCs.Multifunctional nanoscale strategies for enhancing and monitoring blood vessel regeneration Balancing cell migration with matrix degradation enhances gene delivery to cells cultured three-dimensionally within hydrogels.Comparison studies of the in vivo treatment of full-thickness excisional wounds and burns by an artificial bilayer dermal equivalent and J-1 acellular dermal matrix.

P2860

Q24613344-852F0489-F601-49DE-8678-8E21DDD7F3F2 Q24649486-A5A45DE5-2B45-42F0-A9D5-B34162438EFE Q24683317-3D3965A3-E6E8-489C-A3B2-8686BFA20089 Q26824402-21762522-320A-42D5-B81F-BE0E5F8BB55C Q29616603-4286221C-93A8-4764-B397-93C49ABB67B3 Q30354756-288DB7D0-0790-43FA-844D-8B6AE96E7857 Q33518570-3AE7933C-0533-4D5C-84DB-58C04898E22B Q33864915-05439E59-0411-450C-BF0D-3E61A9576261 Q34091796-846DF30B-B30C-469A-B02A-7E06831769CC Q34474842-E949E37C-417A-459B-BB6C-A3CC5AF04206 Q35041201-DE9C9095-3BE7-42FF-9D34-4EBEBEC61595 Q35112949-C4BCBE4B-C687-488E-91AA-9EBC5CC1DA0E Q35539055-010C1432-9A38-498D-B231-BFA1FB58B446 Q36347256-C2B4DE4E-2CB3-4A78-916E-EADCD4D4E44F Q36627789-F0023CC6-1E80-4B05-B62A-84431D8F3B87 Q36717650-AED32C6D-24DD-4E85-9AAF-4921E7144E86 Q36727410-C4AB63DD-36D4-458B-AAB0-AC267D2E3A09 Q36804639-6005BC0C-6F2C-439F-858F-6E3D918EAFFD Q36809751-024C6306-8798-4B21-A3F5-27C2E211CAC4 Q36826532-8D61C0E8-54AB-4DBB-A19B-00134CE379B9 Q37045533-B7C40487-0A51-4910-87AC-13028643011A Q37095873-FE81B144-1484-4AE7-92AF-6E9E71CE0504 Q37164780-78B600E6-5D3E-4ACD-8974-3542492706D3 Q37176404-43A4716A-A4A8-484B-9BE5-2FABA1CF16DE Q37275834-8C8295A8-F4B0-4F5D-90E0-6386A5EF362B Q37363295-C4E4F6D3-29B5-4518-A33B-DBC0D3BBE7E1 Q37735550-9C8F672A-0727-4352-AC3F-150BFDE5BA1B Q37827854-E01CE7F0-130B-4082-8364-5ADA10615285 Q37980646-C011CF35-9268-4647-BE16-CF858A324E27 Q38023826-5A293122-C0DF-4B42-A957-6AEB7084BA0B Q38238902-ADEA3145-3A91-473C-AAD0-12BA39D4860D Q38349634-5A2526CD-DF57-4278-843B-10645F633EEF Q38894255-FA4F552D-C9BB-47D5-9DB1-5D3F8E5EA7BF Q39221799-7C7C3032-D096-4142-AB41-F0DC3CBEB337 Q39416740-5B08F88F-566E-42EB-BD30-2CBBD75928A4 Q41771315-95110920-B61D-4696-BB3D-BE3746CF4207 Q42110886-152F618F-38C4-4651-8627-2A97839481D0 Q42114375-79B1A3CE-0465-473E-A9DA-90539F1790EB Q42285059-E03D92EE-7E99-4AFC-9C44-8E637F9FCED1 Q53547267-A1E0901A-17D3-4110-8108-4BFC85D72213

P2860

Peptide-matrix-mediated gene transfer of an oxygen-insensitive hypoxia-inducible factor-1alpha variant for local induction of angiogenesis.

http://www.wikidata.org/entity/Q34479397

description

2006 nî lūn-bûn

@nan

2006 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Peptide-matrix-mediated gene t ...... cal induction of angiogenesis.

@ast

Peptide-matrix-mediated gene t ...... cal induction of angiogenesis.

@en

Peptide-matrix-mediated gene t ...... cal induction of angiogenesis.

@nl

type

label

Peptide-matrix-mediated gene t ...... cal induction of angiogenesis.

@ast

Peptide-matrix-mediated gene t ...... cal induction of angiogenesis.

@en

Peptide-matrix-mediated gene t ...... cal induction of angiogenesis.

@nl

prefLabel

Peptide-matrix-mediated gene t ...... cal induction of angiogenesis.

@ast

Peptide-matrix-mediated gene t ...... cal induction of angiogenesis.

@en

Peptide-matrix-mediated gene t ...... cal induction of angiogenesis.

@nl

P1433

Q34479397-99E86809-505D-48B8-AFF6-F37CFBF551CA

P1476

Q34479397-D41D0465-F497-4161-A528-80FCB2D9BF64

P2093

Q34479397-3A9D6820-18CE-4A62-9359-C89C3E423AE2

Q34479397-5667787B-BDEE-4E42-910B-8796B9186FE3

Q34479397-880D8FB1-3496-48B6-A97C-B75E51E27FE3

P2860

Q34479397-01B2E78F-02D2-423E-9395-64406C58887D

Q34479397-041194E8-6B9D-44DB-AC4D-1D652653D176

Q34479397-04A6560E-9A3D-4025-B0BA-938B7AAB6BCB

Q34479397-0A4C174A-EBF9-4B23-B385-E23C864DDB06

Q34479397-0B17E0E5-EAE4-4D08-9419-322CC6FC78EE

Q34479397-1299407A-8DB5-4DEE-94D2-C6C46655D004

Q34479397-146CA3D2-5A36-45CE-9AA0-811E03C527B1

Q34479397-186BDF92-99D2-413B-9BB2-19F7D3C5E257

Q34479397-18AD959C-FA87-41E3-957F-778E8574E309

Q34479397-1A663224-9E9C-4C9E-A21A-8940C2A3596E

P304

Q34479397-5B5FE411-1D46-4664-96C7-50F2A08142E8

P31

Q34479397-DFEB5D68-A480-4B18-BF2F-2BFF68CAA0FF

P356

Q34479397-7D473B90-3791-4106-BF6E-6CC3AEF7B05F

P407

Q34479397-03188B12-D639-463C-9FB0-7DF86BFE62BB

P433

Q34479397-A985543A-E20C-434D-B059-BF8F2768E3C4

P478

Q34479397-C407EC37-FFF7-45D3-B7D4-22C3CEE41B63

P50

Q34479397-F5EB478B-0C20-4E4B-9740-BB8F1D5D9DFB

P577

Q34479397-066F1BE3-263F-4C42-9A0C-6319EF67678C

P5875

Q34479397-21090F96-93AD-42BB-81FA-78274C7174E7

P698

Q34479397-00A85856-5AAA-4CD4-B6E8-BF2CB2B033E5

P921

Q34479397-6657FAD8-026D-49A4-A549-3E1140796368

P932

Q34479397-011497B2-F16E-4CE6-BEFD-44593EC1ED70

P356

PNAS.0505964102

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Peptide-matrix-mediated gene t ...... ocal induction of angiogenesis

@en

P2093

Diana Trentin

http://www.w3.org/2001/XMLSchema#string

Heike Hall

http://www.w3.org/2001/XMLSchema#string

Sandra Wechsler

http://www.w3.org/2001/XMLSchema#string

P2860

A conserved family of prolyl-4-hydroxylases that modify HIF

The function of KGF in morphogenesis of epithelium and reepithelialization of wounds

Regulation of hypoxia-inducible factor 1alpha is mediated by an O2-dependent degradation domain via the ubiquitin-proteasome pathway

Site-directed mutagenesis by overlap extension using the polymerase chain reaction

The biology of VEGF and its receptors

Angiogenesis in health and disease

Use of Arabidopsis thaliana defense-related mutants to dissect the plant response to pathogens

Polymer-based gene delivery with low cytotoxicity by a unique balance of side-chain termini.

Characterization of HIF-1 alpha overexpressing HeLa cells and implications for gene therapy.

Gene therapy progress and prospects: therapeutic angiogenesis for limb and myocardial ischemia.

P304

2506-2511

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.0505964102

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

103

http://www.w3.org/2001/XMLSchema#string

P50

Jeffrey A. Hubbell

P577

2006-02-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7300056

http://www.w3.org/2001/XMLSchema#string

P698

16477043

http://www.w3.org/2001/XMLSchema#string

P921

P932

1413769

http://www.w3.org/2001/XMLSchema#string